Orthopediatrics CORP Form 4 insider transactions

Director Terry D. Schlotterback reported acquiring 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director Bryan W. Hughes reported acquiring 2,766 shares of Orthopediatrics Corp. common stock on May 28, 2024.

Director David R. Pelizzon reports acquiring 2,766 shares of Orthopediatrics Corp stock at $0, increasing his direct holdings to 24,547 shares.

Orthopediatrics Corp.'s CEO, David R. Bailey, sold 3,213 shares of common stock on March 11, 2024, to satisfy tax withholding obligations related to vesting restricted shares.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., sold 2,741 shares of common stock on March 11, 2024, to satisfy tax withholding obligations.

Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., sold 2,768 shares of common stock on March 11, 2024, to satisfy tax withholding obligations upon the vesting of restricted shares.

Mark C. Throdahl, a director at Orthopediatrics Corp., sold 2,433 shares of common stock on March 11, 2024, to satisfy tax withholding obligations.

Fred Hite, COO and CFO of Orthopediatrics Corp., sold 3,195 shares of common stock on March 11, 2024, to satisfy tax withholding obligations upon the vesting of restricted shares.